This e-learning course discusses treatment sequencing in advanced hepatocellular carcinoma (HCC). Key clinical questions will be addressed, including:

  • What does the current systemic treatment landscape for advanced HCC look like?
  • What is the role of novel systemic therapies and immunotherapy?
  • What is the impact of treatment sequencing?
  • What are the main adverse events associated with targeted therapy and immunotherapy, including immune-related hepatotoxicity?
  • What will be the future role of tissue-based biomarkers in HCC?